Senior Scientist
Aronora, Inc.
Brandon Markway, PhD, is a Senior Scientist at Aronora, Inc. He has been directly involved in the preclinical development of AB002 (E-WE thrombin) for the acute arterial thrombosis indication for the past seven years. He has been responsible for overseeing manufacturing activities, characterizing the molecule’s activity towards various physiologic substrates, developing assays for batch release and clinical safety (e.g. immunogenicity testing), and managing the Chemistry, Manufacturing, and Controls elements of the initial IND filing for E-WE thrombin. Prior to his position at Aronora, he conducted research on cartilage biology and osteoarthritis (OA) as a postdoctoral fellow and research associate at Oregon Health & Science University.